Rare earth metals used in biodegradable magnesium-based stents do not interfere with proliferation of smooth muscle cells but do induce the upregulation of inflammatory genes

Journal of Biomedical Materials Research - Part A

Volumn 91, Issue 2, 2009, Pages 360-369

  Drynda, Andreas ^a   Deinet, Nicole ^a   Braun, Nicole ^a   Peuster, Matthias ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Biocompatibility; Cell proliferation; Inflammation; Molecular biology; Smooth muscle cell

Indexed keywords

ADVERSE EFFECT; APOPTOTIC; CARDIOVASCULAR STENTS; CELLULAR PROCESS; CONCENTRATION OF; CONCENTRATION RANGES; DEGRADATION PROCESS; DEGRADATION RATE; HIGH CONCENTRATION; HUMAN VASCULAR SMOOTH MUSCLE CELLS; IN-VIVO; INFLAMMATION; INFLAMMATORY GENES; INFLAMMATORY PROCESS; METABOLIC ACTIVITY; QUANTITATIVE REAL TIME PCR; RARE EARTH METALS; SMOOTH MUSCLE CELL; SMOOTH MUSCLE CELLS; TIME POINTS; UP-REGULATION; VASCULAR CELLS;

ANIMAL CELL CULTURE; BIOCHEMISTRY; BIOCOMPATIBILITY; BIOMECHANICS; CELL CULTURE; CELL MEMBRANES; CELL PROLIFERATION; CERIUM; CERIUM COMPOUNDS; CHLORINE COMPOUNDS; DEGRADATION; GENES; LEAD; MAGNESIUM; MECHANICAL PROPERTIES; METABOLISM; METALS; MOLECULAR BIOLOGY; MOLECULAR STRUCTURE; MUSCLE; NEODYMIUM; PATHOLOGY; RARE EARTHS; YTTERBIUM; YTTRIUM;

RARE EARTH ALLOYS;

BIOMATERIAL; CERIUM; DYSPROSIUM; ERBIUM; EUROPIUM; GADOLINIUM; HOLMIUM; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; LANTHANIDE; LANTHANUM; LUTETIUM; MAGNESIUM; NEODYMIUM; PRASEODYMIUM; SAMARIUM; SCANDIUM; TERBIUM; THULIUM; YTTERBIUM; YTTRIUM;

APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STENT; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ABSORBABLE IMPLANTS; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; MAGNESIUM; METALS, RARE EARTH; MYOCYTES, SMOOTH MUSCLE; STENTS; UP-REGULATION;

EID: 70349456551     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32235     Document Type: Article

References (29)

1. Peuster M, Wohlsein P, Brügmann M, Ehlerding M, Seidler K, Fink C, Brauer H, Fischer A, Hausdorf G. A novel approach to temporary stenting: Degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits. Heart 2001;86:563-569. (Pubitemid 32999872)
2. Reclaru L, Lerf R, Eschler PY, Meyer JM. Corrosion behavior of a welded stainless-steel orthopedic implant. Biomaterials 2001;22:269-279. (Pubitemid 30843865)
3. Kraft CN, Diedrich O, Burian B, Schmitt O, Wimmer MA. Microvascular response of striated muscle to metal debris. A comparative in vivo study with titanium and stainless steel. J Bone Joint Surg Br 2003;85:133-141.
4. Peuster M, Fink C, von Schnakenburg C, Hausdorf G. Dissolution of tungsten coils does not produce systemic toxicity but leads to elevated levels of tungsten in the serum and recanalization of the previously occluded vessel. Cardiol Young 2002;12:229-235. (Pubitemid 41238835)
5. Peuster M, Fink C, Wohlsein P, Bruegmann M, Guenther A, Kaese V, Niemeyer M, Haferkamp H, Schnakenburg C. Degradation of tungsten coils implanted into the subclavian artery of New Zealand white rabbits is not associated with local or systemic toxicity. Biomaterials 2003;24:393-399. (Pubitemid 35287512)
6. Ryan MP, Williams DE, Chater RJ, Hutton BM, McPhail DS. Why stainless steel corrodes. Nature 2002;415:770-774.
7. Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: A new principle in cardiovascular implant technology? Heart 2003;89:651-656.
8. Witte F, Kaese V, Haferkamp H, Switzer E, Meyer-Lindenberg A, Wirth CJ, Windhagen H. In vivo corrosion of four magnesium alloys and the associated bone response. Biomaterials 2005;26:3557-3563.
9. Peeters P, Bosiers M, Verbist J, Deloose K, Heublein B. Preliminary results after application of absorbable metal stents in patients with critical limb ischemia. J Endovasc Ther 2005;12:1-5. (Pubitemid 40229382)
10. Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR, Erne P, Haude M, Heublein B, Horrigan M, Ilsley C, Böse D, Koolen J, Lüscher TF, Weissmann N, Waksman R. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: A prospective, non-randomised multicentre trial. Lancet 2007;369:1869-1875. (Pubitemid 46829357)
11. Waksman R, Pakala R, Kuchulakanti PK, Baffour R, Hellinga D, Seabron R, Tio FO, Wittchow E, Hartwig S, Harder C, Rohde R, Heublein B, Andreae A, Waldmann KH, Haverich A. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries. Catheter Cardiovasc Interv 2006;68:607-617. (Pubitemid 44546055)
12. Di Mario C, Griffiths H, Goktekin O, Peeters N, Verbist J, Bosiers M, Deloose K, Heublein B, Rohde R, Kasese V, Ilsley C, Erbel R. Drug-eluting bioabsorbable magnesium stent. J Interv Cardiol 2004;17:391-395.
13. Mordike BL, Ebert T. Magnesium properties-applications-potential. Mater Sci Eng A 2001;302:37-45.
14. Mordike BL. Creep-resistant magnesium alloys. Mater Sci Eng A 2002;324:103-112.
15. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2756.
16. Hirano S, Suzuki KT. Exposure, metabolism, and toxicity of rare earths and related compounds. Environ Health Perspect 1996;104(Suppl 1):85-95. (Pubitemid 26123094)
17. Nemery B. Metal toxicity and the respiratory tract. Eur Respir J 1990;3:202-219.
18. Sullivan TM, Ainsworth SD, Langan EM, Taylor S, Snyder B, Cull D, Youkey J, Laberge M. Effect of endovascular stent strut geometry on vascular injury, myointimal hyperplasia and restenosis. J Vasc Surg 2002;36:143-149. (Pubitemid 41122903)
19. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002;105:2974-2980. (Pubitemid 34693829)
20. Schulz C, Herrmann RA, Beilharz C, Pasquantonio J, Alt E. Coronary stent symmetry and vascular injury determine experimental restenosis. Heart 2000;83:462-467. (Pubitemid 30316767)
21. Drynda A, Hassel T, Hoehn R, Perz A, Bach FW, Peuster M. Development and biocompatibility of a novel corrodible fluoride-coated magnesium-calcium alloy with improved degradation kinetics and adequate mechanical properties for cardiovascular applications. 2008. [Epub ahead of print (DOI: 10.1002/jbm.a.32582)].
22. Peuster M, Fink C, Reckers J, Beerbaum P, von Schnakenburg C. Assessment of subacute inflammatory and proliferative response to coronary stenting in a porcine model by local gene expression studies and histomorphometry. Biomaterials 2004;25:957-963. (Pubitemid 37393286)
23. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Müller KM. Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157-163. (Pubitemid 30061274)
24. Gaspardone A, Versaci F. Coronary stenting and inflammation. Am J Cardiol 2005;96:65L-70L.
25. Santin M, Mikhalovska L, Lloyd AW, Mikhalovsky S, Sigfrid L, Denyer SP, Field S, Terr SD. In vitro host response assessment of biomaterials for cardiovascular stent manufacture. J Mater Sci Mater Med 2004;15:473-477.
26. Schillinger M, Minar E. Restenosis after percutaneous angioplasty: The role of vascular inflammation. Vasc Health Risk Manag 2005;1:73-78.
27. Remick DG. Interleukin-8. Crit Care Med 2005;33:466-467.
28. Dunehoo AL, Anderson M, Majumdar S, Kobayashi N, Berkland C, Siahaan TJ. Cell adhesion molecules for targeted drug delivery. J Pharm Sci 2006;95:1856-1872. (Pubitemid 44433019)
29. Ross J. mRNA stability in mammalian cells. Microbiol Rev 1995;59:423-450.